Grand Theravac Life Sciences (nanjing) Co., Ltd.

This study is testing whether an experimental injection called TVAX-008 can help clear the hepatitis B virus from the body. It involves 48 adults with chronic hepatitis B who have already tried other treatments or are new to treatment. The main goal is to see if the injection saf…

This study is testing whether a new injection called TVAX-008, when given alongside standard antiviral pills, can help people with chronic hepatitis B. The goal is to see if the combination can help patients achieve a key milestone called HBsAg negative status, which indicates be…

This early study is testing a new injection called TVAX-008. It aims to see if it can safely boost the body's immune response in people who have chronic Hepatitis B but currently have very low levels of the virus. The study will enroll 20 adults to check if the injection increase…